MDS Abstracts

Abstracts from the International Congress of Parkinson’s and Movement Disorders.

MENU 
  • Home
  • Meetings Archive
    • 2025 International Congress
    • 2024 International Congress
    • 2023 International Congress
    • 2022 International Congress
    • MDS Virtual Congress 2021
    • MDS Virtual Congress 2020
    • 2019 International Congress
    • 2018 International Congress
    • 2017 International Congress
    • 2016 International Congress
  • Keyword Index
  • Resources
  • Advanced Search
  • 2023 International Congress

    Longitudinal changes in brain networks associated with clinical symptoms in idiopathic rapid eye movement sleep behavior disorder

    N. Wakasugi, T. Takamura, M. Abe, Y. Mukai, N. Nishikawa, T. Hatano, Y. Shimo, K. Ikenaka, H. Kadotani, Y. Sumi, N. Sawamoto, H. Watanabe, H. Mochizuki, N. Hattori, M. Katsuno, Y. Takahashi, R. Takahashi, T. Hanakawa (Tokyo, Japan)

    Objective: We aimed to assess changes in brain functional networks and accompanying symptoms over years in patients with idiopathic rapid eye movement sleep behavior disorder…
  • 2023 International Congress

    Exploring the Effects of Spinal Cord Stimulation for Gait Disturbances in Parkinson’s Disease

    N. Vanegas-Arroyave, K. Kwei, M. Lee, C. Prakash, L. Branco, A. Tarakad, Y. Taneff, N. Ince, A. Viswanathan, B. Najafi (Houston, USA)

    Objective: We sought to investigate the effects of SCS in PD, using placebo stimulation, compared to either tonic or burst stimulation paradigms. Background: Gait disturbances…
  • 2023 International Congress

    Levodopa-induced orthostatic hypotension in a large cohort of patients with Parkinson’s disease undergoing an acute levodopa challenge test

    X. Wang, S. Mei, C. Han, P. Chan (Beijing, China)

    Objective: We aimed to investigate the frequency and associated risk factors for Levodopa-induced orthostatic hypotension (OH) in a large cohort of PD patients underwent acute…
  • 2023 International Congress

    Early cognitive decline in Parkinson’s disease is anticipated by enhanced frontal theta oscillations and minor hallucinations

    F. Bernasconi, J. Pagonabarraga, H. Bejr-Kasem, S. Martinez-Horta, J. Marín-Lahoz, A. Horta-Barba, J. Kulisevsky, O. Blanke (Geneva, Switzerland)

    Objective: Identify alterations associated with minor hallucinations (MH) and their role in cognitive decline in patients with Parkinson’s disease (PD) by merging electroencephalography (EEG) with…
  • 2023 International Congress

    Identification of ZYIL1, a novel NLR family pyrin domain containing 3 protein inhibitor: a potential disease modifier in Parkinson’s disorder

    A. Chatterjee (Ahmedabad, India)

    Objective: Identification and evaluation of the potential of a novel NLR family pyrin domain containing 3 (NLRP3) inflammasome inhibitor (ZYIL1) as a Parkinson’s disease (PD)…
  • 2023 International Congress

    Heart-rate variability as a new marker for freezing predisposition in Parkinson’s disease

    B. Heimler, O. Koren, R. Inzelberg, U. Rosenblum, S. Hassin-Baer, G. Zeilig, R. Bartsch, M. Plotnik (Tel Hashomer, Israel)

    Objective: We aim to investigate for the first time whether it is possible to detect a predisposition for upcoming Freezing of Gait (FoG) events from…
  • 2023 International Congress

    Reliability and validity of automatedly generated vowel space metrics as biomarkers of articulatory impairment severity and progression in early Parkinson’s Disease

    D. Kwaśny, J. Rusz, R. Ullmann, E. Volkova-Volkmar, B. Fehlmann, S. Lambrecht, G. Pagano, T. Kustermann, R. Postuma, M. Lindemann, K. Taylor (Basel, Switzerland)

    Objective: To evaluate the reliability and validity of automatedly generated vowel space metrics from remotely collected smartphone speech samples as biomarkers of articulatory impairment severity…
  • 2023 International Congress

    Population-Scale Long-Read Sequencing to Catalog Structural Variants in Parkinson’s Disease

    K. Billingsley (bethesda, USA)

    Objective: We aimed to generate a population scale long-read sequencing dataset to begin to catalog structural variants in Parkinson’s disease (PD) to identify potential new variants…
  • 2023 International Congress

    Impact of orthostatic hypotension with sleep disturbance on cognition

    A. Ovchynnykova, E. Trufanov (Kyiv, Ukraine)

    Objective: To define features of cognitive decline in a group of patients with orthostatic hypotension combined with sleep disorders. Background: recent data suggest that orthostatic…
  • 2023 International Congress

    Montelukast as disease modifying treatment for Parkinson’s disease: a pilot study.

    J. Wallin, P. Svenningsson (Stockholm, Sweden)

    Objective: To assess safety and tolerability of high dose Montelukast as a possible disease modifying treatment for Parkinson’s disease. Background: Emerging evidence suggests that the…
  • « Previous Page
  • 1
  • …
  • 39
  • 40
  • 41
  • 42
  • 43
  • …
  • 186
  • Next Page »

Most Viewed Abstracts

  • This Month
  • All Time
  • Covid vaccine induced parkinsonism and cognitive dysfunction
  • Life expectancy with and without Parkinson’s disease in the general population
  • What is the appropriate sleep position for Parkinson's disease patients with orthostatic hypotension in the morning?
  • “Magic carpet for freezing of gait ” Evaluating a combination of patterned and pictographic visual cues.
  • Increased Risks of Botulinum Toxin Injection in Patients with Hypermobility Ehlers Danlos Syndrome: A Case Series
  • Effect of marijuana on Essential Tremor: A case report
  • Increased Risks of Botulinum Toxin Injection in Patients with Hypermobility Ehlers Danlos Syndrome: A Case Series
  • Covid vaccine induced parkinsonism and cognitive dysfunction
  • Help & Support
  • About Us
  • Cookies & Privacy
  • Wiley Job Network
  • Terms & Conditions
  • Advertisers & Agents
Copyright © 2026 International Parkinson and Movement Disorder Society. All Rights Reserved.
Wiley